Who Optimizes SG&A Costs Better? Merus N.V. or MiMedx Group, Inc.

Optimizing SG&A Costs: A Tale of Two Companies

In the competitive landscape of corporate finance, optimizing Selling, General, and Administrative (SG&A) expenses is crucial for maintaining profitability. This analysis compares the SG&A cost management of Merus N.V. and MiMedx Group, Inc. over a decade, from 2014 to 2023.

Merus N.V.: A Steady Climb

Merus N.V. has shown a consistent increase in SG&A expenses, starting from a modest $3.85 million in 2014 to nearly $60 million in 2023. This represents a staggering 1,456% increase over the period. Despite the rise, Merus N.V. has managed to keep its expenses relatively low compared to its competitor.

MiMedx Group, Inc.: A Costly Affair

MiMedx Group, Inc., on the other hand, began with $90 million in 2014, peaking at $258 million in 2018, before stabilizing around $211 million in 2023. This indicates a 134% increase, highlighting a more aggressive spending strategy.

Conclusion

While both companies have increased their SG&A expenses, Merus N.V. has demonstrated a more controlled approach, potentially indicating better cost optimization strategies.